Announcement

Collapse
No announcement yet.

Cureus . Perception and Attitude Towards COVID-19 Vaccination Among the Elderly: A Community-Based Cross-Sectional Study

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Cureus . Perception and Attitude Towards COVID-19 Vaccination Among the Elderly: A Community-Based Cross-Sectional Study


    Cureus


    . 2022 Dec 29;14(12):e33108.
    doi: 10.7759/cureus.33108. eCollection 2022 Dec.
    Perception and Attitude Towards COVID-19 Vaccination Among the Elderly: A Community-Based Cross-Sectional Study


    Chirag Sandooja 1 , Jugal Kishore 1 , Aninda Debnath 1 , Aftab Ahmad 1



    Affiliations

    Abstract

    Introduction COVID-19 is one of the most formidable obstacles that humanity has encountered in this century. The death rate was high among the elderly in India; therefore, getting the elderly vaccinated was one of the most important things to do. Objective We conducted this study to assess the perception and attitude about the COVID-19 vaccines among the elderly population. Methods This cross-sectional study was conducted at Fatehpur Beri, New Delhi. We selected 108 participants using systematic random sampling. We used a semi-structured questionnaire to collect the data. Results Out of 108 participants, 52.8% were men. Among them, 9.3% of participants had tested positive before. The average number of days of illness among the participants was 5.3 (SD + 3.5). Males had a higher average day of illness (5.5, SD +3.7) than females (4.9, SD +3.3). Among those who had not been vaccinated, 73.3% of participants said they would receive the vaccine, 6.7% were unsure, and 20% were not willing to receive the vaccine. Conclusion COVID vaccination in an elderly population showed a relatively high vaccine acceptance rate, and the willingness to get the vaccine was also high among the unvaccinated.

    Keywords: coronavirus disease; covaxin; covid 19; covid-19 vaccine; covishield; cross sectional studies; elderly patients; elderly population; kap study; sars-cov-2 (severe acute respiratory syndrome coronavirus -2).

Working...
X